microRNA 4309 (MIR4309)

microRNA 4309 (MIR4309), also referred to as hsa-mir-4309, is nominally listed as a microRNA, a type of small non-coding RNA molecule that typically regulates gene expression post-transcriptionally through RNA silencing or degradation mechanisms[1]. However, as of the current literature and major microRNA databases, there is essentially no functional, disease association, or therapeutic information available for MIR4309. It is not recognized as a target in the sense of typical druggable proteins (such as receptors, enzymes, or ion channels), nor is it found among the well-studied microRNAs implicated in major biological processes or diseases such as cancer, inflammation, or infection. Furthermore, unlike well-characterized microRNAs such as miR-21, miR-93, or miR-30b, which have direct evidence for roles in cell signaling, cancer, or therapy response[3][4][6], there is no known biological function, disease relevance, biomarker status, or pharmacological targeting associated with MIR4309 at this time. The inclusion of "MIR4309" in databases likely derives from automated annotation pipelines, but literature-backed evidence of function, expression, or disease association is missing. Therefore, it is considered problematic as a drug or biomarker target due to the lack of information. Key points of caution: - MIR4309 is not a recognized or established therapeutic target. - There are no documented biological or disease associations in the literature. - It is not listed with validated function in major annotation resources, distinguishing it from other microRNAs with clinical or experimental relevance. Based on the lack of specific evidence for MIR4309, this target entry is likely incorrect or not meaningful for most research or drug discovery purposes at this time.

Other names

hsa-mir-4309MIR4309